Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.
about
Coenzyme Q10 Prevents Insulin Signaling Dysregulation and Inflammation Prior to Development of Insulin Resistance in Male Offspring of a Rat Model of Poor Maternal Nutrition and Accelerated Postnatal Growth.Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.Estimation of ellagic acid and/or repaglinide effects on insulin signaling, oxidative stress, and inflammatory mediators of liver, pancreas, adipose tissue, and brain in insulin resistant/type 2 diabetic rats.CoQ10 Augments Rosuvastatin Neuroprotective Effect in a Model of Global Ischemia via Inhibition of NF-κB/JNK3/Bax and Activation of Akt/FOXO3A/Bim Cues.The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway.Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome.Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
P2860
Q36908576-0233B3C8-20DC-406E-98A7-5C70ADABF005Q38268344-37E51351-8935-47BC-946A-AEF2BB19EFE4Q39136204-3D8FC848-06D6-46D1-8275-6FBE55EDE011Q40524148-FA4A64DD-C72B-46D8-9BA2-10F7A9120E64Q46264282-1AE02E65-F307-45F2-A1AE-4CBDEDF4A5B6Q46679067-A188734F-D83A-4204-B438-6A94B7B80129Q47642022-6307DAE1-987A-4D0E-A88B-68CF6286F488Q48103576-870F0DFD-1C30-418A-91B5-2BC022227D04Q48151784-CFC312C7-CDBF-40F5-A2A9-D7E8B860A995Q48318207-DE2F4FE1-79A7-406D-8505-E624EF99FDB0Q49830695-742C33B3-A506-4811-9ED1-834E8BBEC9A6Q57300294-D868651A-0E6B-405E-8689-5E01BC67EBF0
P2860
Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@ast
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@en
type
label
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@ast
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@en
prefLabel
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@ast
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@en
P2860
P50
P1433
P1476
Novel CoQ10 antidiabetic mecha ...... sulin resistant/diabetic rats.
@en
P2093
Gihan F Asaad
Hanan S El-Abhar
P2860
P304
P356
10.1371/JOURNAL.PONE.0089169
P407
P577
2014-02-20T00:00:00Z